AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
Phase 1B study of subcutaneously administered interleukin 2 in combinationwith 13-cis retinoic acid as maintenance therapy in advanced cancer
Authors: Recchia, F De Filippis, S Rosselli, M Saggio, G Cesta, A Fumagalli, L Rea, S
Citation: F. Recchia et al., Phase 1B study of subcutaneously administered interleukin 2 in combinationwith 13-cis retinoic acid as maintenance therapy in advanced cancer, CLIN CANC R, 7(5), 2001, pp. 1251-1257
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia
Authors: Lissoni, P Bucovec, R Bonfanti, A Giani, L Mandelli, A Roselli, MG Rovelli, F Fumagalli, L
Citation: P. Lissoni et al., Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia, J PINEAL R, 30(2), 2001, pp. 123-126
Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis
Authors: Lazzarin, A Clerici, M Hasson, H Fumagalli, L Ferrante, P Saniabadi, AR Adachi, M Beretta, A
Citation: A. Lazzarin et al., Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis, J CLIN APH, 16(1), 2001, pp. 35-36
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1
Authors: Lissoni, P Malugani, F Bonfanti, A Bucovec, R Secondino, S Brivio, F Ferrari-Bravo, A Ferrante, R Vigore, L Rovelli, F Mandala, M Viviani, S Fumagalli, L Gardani, GS
Citation: P. Lissoni et al., Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1, J BIOL REG, 15(2), 2001, pp. 140-144
K-Cl cotransport modulation by intracellular Mg in erythrocytes from mice bred for low and high Mg levels
Authors: De Franceschi, L Villa-Moruzzi, E Fumagalli, L Brugnara, C Turrini, F Motta, R Veghini, E Corato, C Alper, SL Berton, G
Citation: L. De Franceschi et al., K-Cl cotransport modulation by intracellular Mg in erythrocytes from mice bred for low and high Mg levels, AM J P-CELL, 281(4), 2001, pp. C1385-C1395
A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic cell carcinoma progressing on interleukin-2 alone
Authors: Lissoni, P Rovelli, F Baiocco, N Tangini, G Fumagalli, L
Citation: P. Lissoni et al., A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic cell carcinoma progressing on interleukin-2 alone, ANTICANC R, 21(1B), 2001, pp. 777-779
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion - Results of a phase II study on 31 consecutive patients
Authors: Castagneto, B Zai, S Mutti, L Lazzaro, A Ridolfi, R Piccolini, E Ardizzoni, A Fumagalli, L Valsuani, G Botta, M
Citation: B. Castagneto et al., Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion - Results of a phase II study on 31 consecutive patients, LUNG CANC, 31(2-3), 2001, pp. 303-310
Role of alpha(2)-macroglobulin in regulating amyloid beta-protein neurotoxicity: protective or detrimental factor?
Authors: Fabrizi, C Businaro, R Lauro, GM Fumagalli, L
Citation: C. Fabrizi et al., Role of alpha(2)-macroglobulin in regulating amyloid beta-protein neurotoxicity: protective or detrimental factor?, J NEUROCHEM, 78(2), 2001, pp. 406-412
Altered balance of proteinase inhibitors in atrophic muscle after denervation
Authors: Businaro, R Nori, SL Toesca, A Evangelisti, E De Renzis, G Fumagalli, L
Citation: R. Businaro et al., Altered balance of proteinase inhibitors in atrophic muscle after denervation, MA MA SY SE, 7, 2001, pp. 159-165
The evolution of the thyroid hormone distributor protein transthyretin in the order insectivora, class mammalia
Authors: Prapunpoj, P Richardson, SJ Fumagalli, L Schreiber, G
Citation: P. Prapunpoj et al., The evolution of the thyroid hormone distributor protein transthyretin in the order insectivora, class mammalia, MOL BIOL EV, 17(8), 2000, pp. 1199-1209
Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients
Authors: Brivio, F Lissoni, P Gilardi, R Ferrante, R Vigore, L Curzi, L Uggeri, F Nespoli, A Fumagalli, L
Citation: F. Brivio et al., Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients, J BIOL REG, 14(3), 2000, pp. 200-203
Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients
Authors: Beretta, A Clerici, M Hasson, H Fumagalli, L Trabattoni, D Lillo, F Perrante, P Saniabadi, AR Adachi, M Lazzarin, A
Citation: A. Beretta et al., Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients, J BIOL REG, 14(1), 2000, pp. 27-31
Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer
Authors: Bonfanti, A Lissoni, P Bucovec, R Rovelli, F Brivio, F Fumagalli, L
Citation: A. Bonfanti et al., Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer, INT J B MAR, 15(2), 2000, pp. 161-164
Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer
Authors: Lissoni, P Brivio, F Ferrante, R Vigore, L Vaghi, M Fumagalli, E Bucovec, R Malugani, F Fumagalli, L
Citation: P. Lissoni et al., Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer, INT J B MAR, 15(1), 2000, pp. 22-25
Effects of oncological surgery on endothelin-1 secretion in patients with operable gastric cancer
Authors: Ferrari-Bravo, A Franciosi, C Lissoni, P Fumagalli, L Uggeri, F
Citation: A. Ferrari-bravo et al., Effects of oncological surgery on endothelin-1 secretion in patients with operable gastric cancer, INT J B MAR, 15(1), 2000, pp. 56-57
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma
Authors: Fumagalli, L Zucchetti, M Parisi, I Vigano, MG Zecca, B Careddu, A D'Incalci, M Lazzarin, A
Citation: L. Fumagalli et al., The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma, CANC CHEMOT, 45(6), 2000, pp. 495-501
A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies
Authors: Lissoni, P Bolis, S Brivio, F Fumagalli, L
Citation: P. Lissoni et al., A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies, ANTICANC R, 20(3B), 2000, pp. 2103-2105
Surgery-induced decline in circulating dendritic cells in operable cancer patients: A possible explanation of postoperative immunosuppression
Authors: Brivio, F Gilardi, R Bucocev, R Ferrante, R Rescaldani, R Vigore, L Fumagalli, L Nespoli, A Lissoni, P
Citation: F. Brivio et al., Surgery-induced decline in circulating dendritic cells in operable cancer patients: A possible explanation of postoperative immunosuppression, HEP-GASTRO, 47(35), 2000, pp. 1337-1339
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients
Authors: Bordin, V Giani, L Meregalli, S Bukovec, R Vaghi, MM Mandala, M Paolorossi, F Ardizzoia, A Tancini, G Barni, S Frigerio, F Fumagalli, L Bordoni, A Valusani, G Di Felice, G Lissoni, P
Citation: V. Bordin et al., Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients, UROL INTERN, 64(1), 2000, pp. 3-8
Molecular phylogeny and evolution of Sorex shrews (Soricidae : Insectivora) inferred from mitochondrial DNA sequence data
Authors: Fumagalli, L Taberlet, P Stewart, DT Gielly, L Hausser, J Vogel, P
Citation: L. Fumagalli et al., Molecular phylogeny and evolution of Sorex shrews (Soricidae : Insectivora) inferred from mitochondrial DNA sequence data, MOL PHYL EV, 11(2), 1999, pp. 222-235
Regulation of lymphocyte traffic by adhesion molecules
Authors: Fabbri, M Bianchi, E Fumagalli, L Pardi, R
Citation: M. Fabbri et al., Regulation of lymphocyte traffic by adhesion molecules, INFLAMM RES, 48(5), 1999, pp. 239-246
Pre-operative IL-2 immunoprophylaxis of cancer recurrence: Long-term clinical results of a phase II study in radically operable colorectal cancer
Authors: Brivio, F Lissoni, P Fumagalli, L Girlando, M Marsili, MT Nespoli, A Uggeri, F
Citation: F. Brivio et al., Pre-operative IL-2 immunoprophylaxis of cancer recurrence: Long-term clinical results of a phase II study in radically operable colorectal cancer, ONCOL REP, 6(6), 1999, pp. 1205-1207
Mitochondrial DNA sequence variation within the remnant populations of theendangered numbat (Marsupialia : Myrmecobiidae : Myrmecobius fasciatus)
Authors: Fumagalli, L Moritz, C Taberlet, P Friend, JA
Citation: L. Fumagalli et al., Mitochondrial DNA sequence variation within the remnant populations of theendangered numbat (Marsupialia : Myrmecobiidae : Myrmecobius fasciatus), MOL ECOL, 8(9), 1999, pp. 1545-1549
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease
Authors: Lissoni, P Vigore, L Ferranti, R Bukovec, R Meregalli, S Mandala, M Barni, S Tancini, G Fumagalli, L Giani, L
Citation: P. Lissoni et al., Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease, J BIOL REG, 13(4), 1999, pp. 216-219
Which immunological parameters ave clinically essential to monitor IL-2 cancer immunotherapy?
Authors: Lissoni, P Brivio, F Viviani, S Fumagalli, L
Citation: P. Lissoni et al., Which immunological parameters ave clinically essential to monitor IL-2 cancer immunotherapy?, J BIOL REG, 13(2), 1999, pp. 110-114
Risultati: 1-25 | 26-35